Literature DB >> 8981596

Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine.

M G Feenstra1, H van Galen, P J Te Riele, M H Botterblom, M Mirmiran.   

Abstract

Early postnatal treatment with the antidepressant drug clomipramine has repeatedly been shown to lead to behavioural and physiological changes in adult rats. To provide some neurochemical correlates to these studies we have measured a number of monoaminergic parameters in the brains of adult (one year old) rats that were treated twice daily with 15 mg/kg clomipramine from postnatal day 2-14. The most consistent finding was that the hypothalamic levels of serotonin (5-HT) were decreased and those of the dopamine metabolite dihydroxyphenylacetic acid (DOPAC) were increased in rats irrespectively whether they went through a range of behavioural and physiological tests or not. The numbers of beta-adrenoceptors in the frontal cortex and of alpha 2-adrenoceptors in the amygdala/piriform cortex were not changed. The decrease in hypothalamic 5-HT concentrations appears to be up to now the most consistent neurochemical alteration in adult rats that were neonatally treated with antidepressant drugs. It is, however, not clear what the relation is with the functional changes in these rats, that are proposed by some authors as an animal model for depression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981596     DOI: 10.1016/s0091-3057(96)00276-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

Review 1.  Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Authors:  Matthew E Glover; Sarah M Clinton
Journal:  Int J Dev Neurosci       Date:  2016-05-07       Impact factor: 2.457

2.  Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

Authors:  Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

3.  Sleep-related epilepsy in a Long-Evans hooded rat model of depression.

Authors:  Angela L McDowell; Kingman P Strohl; Pingfu Feng
Journal:  Sleep Breath       Date:  2011-12-29       Impact factor: 2.816

4.  Neonatal citalopram exposure produces lasting changes in behavior which are reversed by adult imipramine treatment.

Authors:  Dorota Maciag; Lashondra Williams; David Coppinger; Ian A Paul
Journal:  Eur J Pharmacol       Date:  2006-02-14       Impact factor: 4.432

5.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

6.  Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine.

Authors:  P Feng; D Vurbic; Z Wu; Y Hu; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-09       Impact factor: 4.153

7.  Developmental exposure to fluoxetine modulates the serotonin system in hypothalamus.

Authors:  Cecilia Berg; Tobias Backström; Svante Winberg; Richard Lindberg; Ingvar Brandt
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.